深圳新宙邦科技股份有限公司 2025 年限制性股票激励计划首次授予部分激励对象名单 （授予日） | 序号 | 姓名 | 国籍 | 职务 | 获授的限制 | 占授予限制 | 占公司股 | | --- | --- | --- | --- | --- | --- | --- | | | | | | 性股票数量 | 性股票总数 | 本总额的 | | | | | | （万股） | 的比例 | 比例 | | 1 | 谢伟东 | 中国 | 董事、副总裁 | 20.00 | 1.474% | 0.027% | | 2 | 周艾平 | 中国 | 董事、常务副 | 15.00 | 1.105% | 0.020% | | | | | 总裁 | | | | | 3 | 姜希松 | 中国 | 副总裁 | 15.00 | 1.105% | 0.020% | | 4 | 宋慧 | 中国 | 副总裁 | 10.00 | 0.737% | 0.013% | | 5 | 黄瑶 | 中国 | 财务总监 | 10.00 | 0.737% | 0.013% | | 6 | 贺靖策 | 中国 | 董事会秘书 | 10.00 | 0.737% | 0.0 ...

证券代码：300037 证券简称：新宙邦 公告编号：2025-048 债券代码：123158 债券简称：宙邦转债 深圳新宙邦科技股份有限公司 董事会薪酬与考核委员会 关于公司 2025 年限制性股票激励计划 首次授予激励对象名单（授予日）的核查意见 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 深圳新宙邦科技股份有限公司（以下简称"公司"）董事会薪酬与考核委员 会依据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共 和国证券法》（以下简称"《证券法》"）、《上市公司股权激励管理办法》（以 下简称"《管理办法》"）、《深圳证券交易所创业板股票上市规则》（以下简 称"《上市规则》"）、《深圳证券交易所创业板上市公司自律监管指南第 1 号 ——业务办理》（以下简称"《自律监管指南》"）等相关法律、法规、规范性 文件和《深圳新宙邦科技股份有限公司章程》（以下简称"《公司章程》"）的 有关规定，对公司 2025 年限制性股票激励计划（以下简称"本激励计划"）首 次授予激励对象名单（授予日）进行审核，发表核查意见如下： 1、鉴于 2025 年限制性股票激 ...

北京市中伦（深圳）律师事务所 关于深圳新宙邦科技股份有限公司 2025年限制性股票激励计划调整 及首次授予相关事项的 法律意见书 二〇二五年四月 北京 • 上海 • 深圳 • 广州 • 武汉 • 成都 • 重庆 • 青岛 • 杭州 • 南京 • 海口 • 东京 • 香港 • 伦敦 • 纽约 • 洛杉矶 • 旧金山 • 阿拉木图 Beijing • Shanghai • Shenzhen • Guangzhou • Wuhan • Chengdu • Chongqing • Qingdao • Hangzhou • Nanjing • Haikou • Tokyo • Hong Kong • London • New York • Los Angeles • San Francisco • Almaty | 一、 | 本次调整及本次授予的批准和授权 2 | | --- | --- | | 二、 | 本次调整 3 | | 三、 | 本次授予 4 | | 四、 | 结论意见 6 | 法律意见书 释义 在本法律意见书中，除非另有说明，以下简称或用语具有如下含义： | 公司/新宙邦 | 指 | 深圳新宙邦科技股份有限公 ...

Financial Performance - The company's revenue for Q1 2025 reached ¥2,002,426,500.83, representing a 32.14% increase compared to ¥1,515,396,628.01 in the same period last year[5] - Net profit attributable to shareholders was ¥229,877,499.61, up 39.30% from ¥165,018,629.25 year-on-year[5] - Total profit for the period was ¥269,824,841.39, reflecting a 43.79% increase compared to the previous year[11] - Operating profit amounted to ¥270,153,732.02, up from ¥188,166,033.46, reflecting a growth of 43.5%[25] - Net profit for the period was ¥231,500,664.39, compared to ¥163,112,047.34, representing a year-over-year increase of 42.0%[25] - The total comprehensive income amounted to ¥273.22 million, compared to ¥113.53 million in the prior period, indicating a significant increase of 140.5%[26] Earnings Per Share - Basic earnings per share increased by 40.91% to ¥0.31, while diluted earnings per share rose by 52.38% to ¥0.32[5] - Basic earnings per share rose to ¥0.31 from ¥0.22, reflecting a growth of 40.9%[26] Cash Flow - The net cash flow from operating activities improved by 28.81%, amounting to -¥286,232,096.13, compared to -¥402,073,475.15 in the previous year[12] - The net cash flow from operating activities was negative at ¥286.23 million, an improvement from a negative ¥402.07 million in the previous period[29] - Cash inflow from investment activities totaled approximately ¥1.03 billion, compared to ¥955.92 million in the prior period, showing an increase of 7.5%[29] - The net cash flow from financing activities was negative at ¥429.33 million, a decline from a positive ¥70.68 million in the previous period[30] - The company’s total cash outflow from operating activities was approximately ¥1.80 billion, down from ¥2.08 billion in the previous period, indicating a reduction of 13.4%[29] Assets and Liabilities - Total assets at the end of the reporting period were ¥17,585,582,769.51, a slight decrease of 0.21% from the previous year-end[5] - Total liabilities decreased to ¥7,116,730,336.99 from ¥7,400,503,455.58, a reduction of 3.8%[23] - Current liabilities decreased to ¥4,408,775,786.88 from ¥4,630,479,743.86, a decline of 4.8%[23] - Long-term borrowings reduced to ¥484,632,000.00 from ¥594,632,000.00, a decrease of 18.5%[23] - Cash and cash equivalents decreased to ¥1,671,959,632.72 from ¥2,744,564,985.22, a drop of 39.0%[22] - Total cash and cash equivalents at the end of the period were approximately ¥1.67 billion, down from ¥1.72 billion in the previous period[30] Shareholder Information - The total number of common shareholders at the end of the reporting period is 46,988[14] - The largest shareholder, Qin Jiusan, holds 13.63% of the shares, totaling 102,779,885 shares[14] - The top 10 shareholders hold a significant portion of the shares, with the top three alone accounting for 26.16% of the total shares[14] - The company has a total of 207,791,612 shares under lock-up agreements, primarily due to executive lock-up periods[18] - The company has not reported any changes in the participation of major shareholders in margin financing and securities lending activities[15] - The company has not issued any new shares or conducted any capital increases during the reporting period[16] - The company has a total of 0 preferred shareholders at the end of the reporting period[16] Investment and Expenses - The company reported a significant increase in investment income, which rose by 486.76% to ¥11,760,331.03, due to reduced investment losses from associates[11] - The company's operating costs increased by 36.97% to ¥1,510,814,021.85, primarily due to expanded sales volume[10] - Research and development expenses rose to ¥120,858,575.27 from ¥97,127,667.82, an increase of 24.4%[25] - Inventory increased to ¥1,127,754,003.77 from ¥997,032,283.65, reflecting a growth of 13.1%[22] Other Financial Metrics - The company has not completed any conversions of the "Zhou Bang Convertible Bonds" during Q1 2025, resulting in 0 shares converted into "New Zhou Bang" stock[20] - As of the end of Q1 2025, the company has 19,694,036 convertible bonds remaining, with a total face value of RMB 1,969,403,600[20]

Investment Rating - The report maintains a "Buy" rating for specific companies in the chemical industry, particularly in the compound fertilizer and pesticide sectors, while recommending "Hold" for others [17]. Core Insights - The chemical industry is experiencing an optimization in supply and demand dynamics, leading to a recovery in the compound fertilizer, metal chromium, and niche pesticide markets. The report highlights investment opportunities in undervalued high-growth companies [3][4]. - The report emphasizes the positive performance of listed companies in Q1 2025, particularly in the compound fertilizer sector, and suggests focusing on companies like Xin Yang Feng, Stanley, and Yun Tu Holdings for investment opportunities [3][4]. - The report notes that metal chromium prices have surged to 75,000 CNY/ton, a week-on-week increase of 7,500 CNY/ton, driven by rising demand from the stainless steel sector and new military spending in Europe [3][4]. - The agricultural chemical market is entering its traditional peak season, with stable trading volumes for seasonal crop pesticides. Specific products like Acetochlor and Avermectin are seeing price increases, with recommendations for companies like Xian Da and Li Min [3][4]. Summary by Sections Industry Dynamics - Current macroeconomic conditions in the chemical sector indicate a stabilization in oil prices due to geopolitical factors and OPEC+ production increases, while coal prices are expected to decline in the medium term [4][6]. - The chemical industry PPI data shows a gradual recovery from negative values, with March 2025 PPI at -2.8% year-on-year, indicating a potential bottoming out of the cycle [6][8]. Fertilizer and Pesticide Sector - The report highlights that the domestic urea price is currently at 1,800 CNY/ton, with a slight week-on-week decline of 0.6%. The compound fertilizer sector is experiencing a decrease in operating rates, leading to increased inventory levels [10]. - The pesticide market is witnessing a seasonal peak, with stable trading volumes and price adjustments in various pesticide products, including a price increase for Pyrazole [10][19]. Chemical Products Pricing and Inventory Changes - The report provides detailed pricing data for various chemical products, indicating fluctuations in prices for PTA, MEG, and PVC, with specific attention to the impact of raw material costs and market demand [10][11][12]. - The report notes that the market for fluorinated chemicals is facing supply constraints due to mining restrictions, while the demand remains weak, leading to price adjustments [12][19]. Company Recommendations - The report recommends several companies for investment based on their growth potential and market positioning, including Yangnong Chemical, Runfeng Co., and Yun Tianhua in the fertilizer and pesticide sectors [17][18]. - Companies in the tire and fluorochemical sectors are also highlighted for their potential benefits from recovering domestic demand and cost reductions [3][17].

Investment Rating - The report indicates a declining trend in public fund allocation to the chemical industry, with the allocation ratio dropping to 4.1% in Q1 2025, down 1.6 percentage points year-on-year and 0.7 percentage points quarter-on-quarter, reflecting a historical low level [1][11]. Core Insights - The focus of public funds has shifted, with a notable decrease in the concentration of holdings in leading companies within the chemical sector. The top ten heavyweights' market capitalization share fell from 46.2% in Q4 2024 to 41.9% in Q1 2025 [1]. - Attention has been primarily directed towards the civil explosives and fluorochemical sectors in Q1 2025, with significant increases in holdings for companies like Guangdong Hongda and Zhenhua Co., while reductions were seen in companies such as Wanhua Chemical and Xinzhou Bang [2][3]. - The report highlights a strong interest in sectors with price increase potential, such as fluorochemicals, chromium salts, and pesticides, alongside improving supply-demand dynamics in the civil explosives sector [3]. Summary by Sections Public Fund Allocation Trends - The allocation of public funds to the chemical industry has been on a downward trajectory since Q2 2022, with the market capitalization share decreasing to 4.1% in Q1 2025, marking a significant decline from previous years [11][12]. Individual Stock Movements - Key stocks that saw increased holdings include Guangdong Hongda, Zhenhua Co., and Saint Spring Group, while major reductions were noted for Wanhua Chemical and Xinzhou Bang [2][16]. - The top ten companies by market capitalization in the chemical sector accounted for 52.2% of total holdings, a decrease of 3.3 percentage points [11][15]. Sector Performance - The report identifies the top five sectors by fund holdings in Q1 2025 as other chemical products (13.36 billion), polyurethane (5.91 billion), tires (5.18 billion), fluorochemicals and refrigerants (4.96 billion), and other chemical raw materials (3.85 billion) [24]. Investment Recommendations - The report suggests focusing on sectors with price increase potential and strong domestic demand, particularly civil explosives, while also highlighting opportunities in new materials such as AI materials [4].

深圳新宙邦科技股份有限公司 关于不向下修正宙邦转债转股价格的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： | 证券代码：300037 | 证券简称：新宙邦 公告编号：2025-036 | | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | 1、截至 2025 年 4 月 24 日，深圳新宙邦科技股份有限公司（以下简称"公 司"）股票已出现任意连续三十个交易日中至少有十五个交易日的收盘价低于当 期转股价格的 80%的情形，触发"宙邦转债"转股价格向下修正条件。 2、2025 年 4 月 24 日，经公司第六届董事会第二十一次会议审议通过，董 事会决定本次暂不向下修正转股价格。且自本次董事会审议通过次一交易日起的 6 个月内（即 2025 年 4 月 25 日至 2025 年 10 月 24 日），如再次触发"宙邦转 债"转股价格向下修正条件，亦不提出向下修正方案。 自本次董事会审议通过之日起满 6 个月之后（即下一触发转股价格修正条件 的期间从 2025 年 10 月 25 日重新起算），若再次触发"宙邦转债" ...

| 证券简称：新宙邦 证券代码：300037 | 公告编号：2025-035 | | --- | --- | | 债券代码：123158 债券简称：宙邦转债 | | 经表决形成如下决议： 一、审议通过了《关于不向下修正宙邦转债转股价格的议案》 截至 2025 年 4 月 24 日，公司股票已出现任意连续三十个交易日中至少有十 五个交易日的收盘价低于当期转股价格的 80%的情形，触发"宙邦转债"转股价 格向下修正条件。 公司董事会综合考虑公司的基本情况、股价走势、市场环境等多重因素，以 及对公司长期稳健发展与内在价值的信心，决定本次不向下修正"宙邦转债"转 股价格。且自本次董事会审议通过次一交易日起的 6 个月内（即 2025 年 4 月 25 日至 2025 年 10 月 24 日），如再次触发"宙邦转债"转股价格向下修正条件， 亦不提出向下修正方案。自本次董事会审议通过之日起满 6 个月之后（即下一触 发转股价格修正条件的期间从 2025 年 10 月 25 日重新起算），若再次触发"宙 邦转债"转股价格的向下修正条款，届时公司将按照相关规定履行审议程序，决 定是否行使"宙邦转债"转股价格的向下修正权利。 ...

Core Viewpoint - The domestic electrolyte market in Q1 2025 shows significant growth driven by increasing demand from the electric vehicle and energy storage sectors, with a total production of 435,900 tons, representing a year-on-year increase of 75.9% [2][4]. Group 1: Market Overview - The leading companies in the electrolyte market are Guangzhou Tinci, BYD, and New Zhongbang, with market shares of 33%, 18%, and 13.6% respectively, collectively accounting for 64.6% of total production [4]. - The competition among second-tier companies, including Shida Shenghua, Zhuhai Saive, and Xianghe Kunlun, is intense, with each holding market shares of around 4%-5% [4][8]. - The overall market structure is characterized by a "stronger getting stronger" trend, where technology, capital, and customer resources become core competitive barriers [2][8]. Group 2: Future Projections - Q2 2025 is expected to continue the growth trend, with a conservative estimate of a 5%-8% quarter-on-quarter increase, potentially exceeding 450,000 tons in total production [6][7]. - Leading companies like Guangzhou Tinci and BYD are likely to further expand their market share due to scale effects and cost control capabilities [7]. - The industry is anticipated to face both structural opportunities and challenges, with a focus on "cost reduction and efficiency enhancement" and "high-end development" [8]. Group 3: Driving Factors - The recovery in downstream demand is supported by seasonal increases in electric vehicle sales and the commencement of energy storage projects [9]. - The stabilization of raw material prices, particularly lithium hexafluorophosphate, is expected to support the release of production capacity [9]. - Favorable policies driven by national "dual carbon" goals are likely to continue to enhance the industry [9].